|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Ligand Pharmaceuticals (NASDAQ: LGND) through any online brokerage.
The latest price target for Ligand Pharmaceuticals (NASDAQ: LGND) was reported by Barclays on May 4, 2021. The analyst firm set a price target for 190.00 expecting LGND to rise to within 12 months (a possible 53.45% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Ligand Pharmaceuticals (NASDAQ: LGND) is $123.82 last updated Tue Jun 15 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Ligand Pharmaceuticals. The last dividend paid out to investors was $0.00 on April 3, 2007.
There is no upcoming split for Ligand Pharmaceuticals.
Ligand Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.